The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
S. 4318·119th Congress·Introduced Apr 16, 2026

Breast Cancer Stamp Reauthorization Act

IntroducedGovernment Operations and PoliticsNarrow
View bill text
Sponsor
Sen. Rosen, Jacky [D-NV]
Committees
Homeland Security and Governmental Affairs Committee (primary)
Last action
Apr 16, 2026

Bottom line

The bill reauthorizes the Breast Cancer Research semipostal stamp program for another decade, ensuring continued funding for breast cancer research through stamp sales.

What it actually does

This bill extends the authority of the United States Postal Service to issue a semipostal stamp dedicated to raising funds for breast cancer research. It specifically changes the expiration date for this authority from 2027 to 2037, allowing the program to continue for an additional ten years. This ensures that a portion of the proceeds from the sale of these stamps will continue to support breast cancer research.

Section 2

Extension of Breast Cancer Research Semipostal Stamp Authority

prominently featuredstraightforward

This section amends Section 414(h) of title 39, United States Code, which governs the authority of the United States Postal Service to issue semipostal stamps for breast cancer research. The current law states that this authority expires in 2027. This bill changes that date to 2037, effectively extending the program for an additional ten years. This means the Postal Service can continue to produce and sell the Breast Cancer Research stamp, with a portion of the sale price above the regular postage rate being donated to breast cancer research, until the end of 2037.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
Ask Ledger AI about this